Shares of Trillium Therapeutics were skyrocketing over 40% on a $25 million Pfizer investment this week. The clinical-stage immuno-oncology company developing innovative therapies for the treatment of cancer, announced that it has received an equity investment of $25 million from Pfizer Inc. Shares may have also experienced a pop thanks to optimism over the impressive … Continue reading “Trillium Therapeutics Shares Explode on Pfizer Investment”
